Sellas Life Sciences Group, Inc.
SLS
Revenue
0.00
0.000.00%
3 Months ChangeAssets
15.12M
▼-9.32M▼-38.12%
3 Months ChangeLiabilities
12.21M
▼-2.54M▼-17.25%
3 Months ChangeFree Cash Flow
-13.22M
▼-1.65M▼-14.24%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0001104659-24-106261
2024-08-13
Form 8-K
ID: 0001390478-24-000016
2024-08-13
Form 10-Q
ID: 0001390478-24-000015
2024-08-01
Form 8-K
ID: 0001104659-24-084952
2024-06-21
Form 8-K
ID: 0001104659-24-073957
2024-05-14
Form 8-K
ID: 0001390478-24-000011
2024-05-14
Form 10-Q
ID: 0001390478-24-000010
2024-03-28
Form 8-K
ID: 0001390478-24-000005
2024-03-28
Form 8-K
ID: 0001104659-24-040176
2024-03-15
Form 8-K
ID: 0001104659-24-035028